Biotech | April 25, 2022
CanSinoBIO rebrands to reflect commitment to life sciences research
This is the first major brand refresh of CanSinoBIO since its inception in 2009
This is the first major brand refresh of CanSinoBIO since its inception in 2009
Under the terms of the partnership agreement, Comera will develop a differentiated formulation of an Intas product using Comera's innovative proprietary SQore formulation platform
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
Through this partnership, Premas will connect with genomics labs to provide automated NGS solutions
The facility will produce 150 million vaccine doses per year
The investment will accelerate the overall Sarclisa development program
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
The company will collaborate with U.S.-based colleagues to help life sciences companies improve commercial effectiveness
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
Subscribe To Our Newsletter & Stay Updated
